Product Name:7-(3-aminopropyl)-5,7-diazaspiro[3.4]octane-6,8-dione

IUPAC Name:7-(3-aminopropyl)-5,7-diazaspiro[3.4]octane-6,8-dione

CAS:1368587-97-6
Molecular Formula:C9H15N3O2
Purity:95%+
Catalog Number:CM440622
Molecular Weight:197.24

Packing Unit Available Stock Price($) Quantity
CM440622-250mg 4-5 Weeks ƿƈǪ
CM440622-500mg 4-5 Weeks ȃŗľ
CM440622-1g 5-6 Weeks ƈŤƈƈ

For R&D use only.

Inquiry Form

   refresh    

Product Details

CAS NO:1368587-97-6
Molecular Formula:C9H15N3O2
Melting Point:-
Smiles Code:NCCCN1C(=O)NC2(CCC2)C1=O
Density:
Catalog Number:CM440622
Molecular Weight:197.24
Boiling Point:
MDL No:MFCD21909216
Storage:

Category Infos

Cyclobutanes
The molecular structure of cyclobutane has four carbon atoms, and its four carbon atoms are not in the same plane, which is the folded conformation of cyclobutane. Cyclobutane itself is not of commercial or biological interest, but more complex derivatives are important in biology and biotechnology. Currently, nine FDA-approved drugs contain the cyclobutane structure. From the perspective of therapeutic areas, cyclobutyl drugs are mainly distributed in popular areas such as tumors, neurological diseases, infectious diseases, endocrine and metabolic diseases.
Imidazolidines
Imidazolidine is a heterocyclic compound (CH2)2(NH)2CH2. The parental imidazolidines are less studied, but related compounds substituted on one or both nitrogen centers are more common. Generally, they are colorless, polar, basic compounds. Imidazolidines are examples of cyclic 5-membered general amines. Imidazolidine derivatives are key components in the development of bioactive compounds for the treatment of various diseases, especially Chagas disease. In fact, other studies have shown that imidazoline-2,4-diones have a wide range of pharmacological activities, including anticonvulsant, antiarrhythmic, and antiparasitic.
imidazolidine supplier
As a imidazolidine supplier,we sincerely welcome the new and old friends from home and abroad to synergize with our company and share the benefits and opportunities.